CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France; INSERM, CIC-1402 Team 5 ALIVE, Poitiers, France; Université de Poitiers, Faculté de Médecine et de Pharmacie de Poitiers, Poitiers, France.
CHU de Poitiers, Service des Urgences et SAMU 86, Poitiers, France; Université de Poitiers, Faculté de Médecine et de Pharmacie de Poitiers, Poitiers, France.
Am J Emerg Med. 2020 Jul;38(7):1508-1514. doi: 10.1016/j.ajem.2020.04.091. Epub 2020 May 4.
The use of high-flow oxygen therapy (HFOT) through nasal cannula for the management of acute respiratory failure at the emergency department (ED) has been only sparsely studied. We conducted a systematic review of randomized-controlled and quasi-experimental studies comparing the early use of HFOT versus conventional oxygen therapy (COT) in patients with acute respiratory failure admitted to EDs.
A systematic research of literature was carried out for all published control trials comparing HFOT with COT in adult patients admitted in EDs. Eligible data were extracted from Medline, Embase, Pascal, Web of Science and the Cochrane database. The primary outcome was the need for mechanical ventilation, i.e. intubation or non-invasive ventilation as rescue therapy. Secondary outcomes included respiratory rate, dyspnea level, ED length of stay, intubation and mortality.
Out of 1829 studies screened, five studies including 673 patients were retained in the analysis (350 patients treated with HFOT and 323 treated with COT). The need for mechanical ventilation was similar in both treatments (RR = 0.75; 95% CI 0.41 to 1.35; P = 0.31; I = 16%). Respiratory rate was lower with HFOT (Mean difference (MD) = -3.14 breaths/min; 95% CI = -4.9 to -1.4; P < 0.001; I = 39%), whereas sensation of dyspnea did not differ. (MD = -1.04; 95% CI = -2.29 to -0.22; P = 0.08; I = 67%). ED length of stay and mortality were similar between groups.
The early use of HFOT in patients admitted to an ED for acute respiratory failure did not reduce the need for mechanical ventilation as compared to COT. However, HFOT decreased respiratory rate.
PROSPERO ID CRD42019125696.
经鼻高流量氧疗(HFOT)在急诊科(ED)用于急性呼吸衰竭的管理的应用仅有少量研究。我们对比较 ED 收治的急性呼吸衰竭患者早期使用 HFOT 与常规氧疗(COT)的随机对照和准实验研究进行了系统评价。
对所有比较成人 ED 收治患者 HFOT 与 COT 的发表对照试验进行了系统文献检索。从 Medline、Embase、Pascal、Web of Science 和 Cochrane 数据库提取合格数据。主要结局是需要机械通气,即插管或无创通气作为抢救治疗。次要结局包括呼吸频率、呼吸困难程度、ED 住院时间、插管和死亡率。
在筛选出的 1829 项研究中,有 5 项研究(包括 673 例患者)纳入分析(HFOT 治疗 350 例,COT 治疗 323 例)。两种治疗方法的机械通气需求相似(RR=0.75;95%CI 0.41 至 1.35;P=0.31;I²=16%)。HFOT 的呼吸频率较低(MD=-3.14 次/分钟;95%CI-4.9 至-1.4;P<0.001;I²=39%),而呼吸困难感觉无差异(MD=-1.04;95%CI-2.29 至-0.22;P=0.08;I²=67%)。两组 ED 住院时间和死亡率相似。
与 COT 相比,HFOT 早期用于 ED 收治的急性呼吸衰竭患者并未降低机械通气的需求。然而,HFOT 降低了呼吸频率。
PROSPERO ID CRD42019125696。